It's holding actually surprisingly well. Quite low volume for a news like this. We'll see real reaction probably on Monday when Sweden is open again. Let's hope the nervous Nellies over there won't freak out and put us back on the sixty cent level.
Not enough with the bad effects the dilution will have on the stockprice, now we once again have to wait for the 0.80$-buyers to sell of 12.000.000 shares at 0.81$ before the stockprice can rise over that again. And once again, this proves how far away epicept really is from closing a comercial deal, they are really desperat now! Partner Q4 -08? lol -09? -10? ever?
Something is wrong, very wrong, either with the drug or the managment, maybe both! Well at least managment gets paid a couple of millions$! They sure deserve it! Great job guys!
0.6 next week? Or have people gotten enough of this shit this time? Maybe 0.3$? What an joke this company is.
As epicepto used to say, they only use ceplene as a bait to milk investors, they know they can't sell it, thats why they just keep on "negotiating".